 The Biomedical Advanced Research and Development Authority BARDA has awarded an option under Paratek Pharmaceuticals Incs NASDAQ: PRTK Project BioShield contract. Related Link: Parateks Antibiotic Gets FDA Orphan Drug Tag For Lung Infection. 